23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Remyelination therapies: a new direction and challenge in multiple sclerosis

      , ,
      Nature Reviews Drug Discovery
      Springer Nature

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Restoring damaged myelin could reverse the neurological effects observed in patients with multiple sclerosis. In this Review, Yong and colleagues discuss the progress made in remyelinating therapies, including novel and potential repurposed agents, and highlight the challenges in preclinical and clinical development for such drugs.

          Related collections

          Author and article information

          Journal
          Nature Reviews Drug Discovery
          Nat Rev Drug Discov
          Springer Nature
          1474-1776
          1474-1784
          July 7 2017
          July 7 2017
          :
          :
          Article
          10.1038/nrd.2017.115
          28685761
          ecc4c465-bf86-45df-aa3f-bcd479a99f76
          © 2017
          History

          Comments

          Comment on this article